Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.49)
# 245
Out of 5,182 analysts
563
Total ratings
51.59%
Success rate
22.12%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Maintains: Buy | $27 → $37 | $19.43 | +90.43% | 17 | Jan 9, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $17.59 | +13.70% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $2.46 | +103.25% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $573.46 | -12.81% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $185.95 | +4.33% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $7.53 | +59.36% | 18 | Jul 29, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $7.00 | +228.57% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $88.07 | -31.87% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $21.80 | +46.79% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $436.59 | +25.98% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $140.98 | -14.88% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.61 | +396.89% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $5.28 | -62.12% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $36.25 | -3.45% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $10.67 | +31.21% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $35.61 | -1.71% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $6.20 | +125.81% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $46.83 | +60.15% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $19.21 | +97.81% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $11.31 | +121.04% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $20.13 | +58.97% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.58 | +249.65% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $19.97 | -19.88% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $10.62 | +125.99% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.87 | +318.12% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $130.65 | -70.91% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $130.22 | +29.01% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.73 | +302.93% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.99 | +150.63% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.34 | +199.73% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $34.35 | -41.78% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.74 | +591.64% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.27 | +146.68% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.12 | +35.47% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.32 | +332.33% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.27 | +1,081.10% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $25.64 | +36.51% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $10.30 | +628.51% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.12 | +124.36% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.38 | +624.64% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.55 | +27,167.77% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.51 | +313.51% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $1.68 | +792.86% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.91 | +4,308.69% | 3 | Mar 16, 2022 |
KalVista Pharmaceuticals
Jan 9, 2026
Maintains: Buy
Price Target: $27 → $37
Current: $19.43
Upside: +90.43%
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $17.59
Upside: +13.70%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $2.46
Upside: +103.25%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $573.46
Upside: -12.81%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $185.95
Upside: +4.33%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $7.53
Upside: +59.36%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $7.00
Upside: +228.57%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $88.07
Upside: -31.87%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $21.80
Upside: +46.79%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $436.59
Upside: +25.98%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $140.98
Upside: -14.88%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.61
Upside: +396.89%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $5.28
Upside: -62.12%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $36.25
Upside: -3.45%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $10.67
Upside: +31.21%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $35.61
Upside: -1.71%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $6.20
Upside: +125.81%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $46.83
Upside: +60.15%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $19.21
Upside: +97.81%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $11.31
Upside: +121.04%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $20.13
Upside: +58.97%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.58
Upside: +249.65%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $19.97
Upside: -19.88%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $10.62
Upside: +125.99%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.87
Upside: +318.12%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $130.65
Upside: -70.91%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $130.22
Upside: +29.01%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.73
Upside: +302.93%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $3.99
Upside: +150.63%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.34
Upside: +199.73%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $34.35
Upside: -41.78%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.74
Upside: +591.64%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.27
Upside: +146.68%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $8.12
Upside: +35.47%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.32
Upside: +332.33%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.27
Upside: +1,081.10%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $25.64
Upside: +36.51%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $10.30
Upside: +628.51%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.12
Upside: +124.36%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.38
Upside: +624.64%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.55
Upside: +27,167.77%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.51
Upside: +313.51%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $1.68
Upside: +792.86%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.91
Upside: +4,308.69%